Trending Down-0.2600 (-1.6362%)
  • Bid / Lots
    15.5600/ 4
  • Ask / Lots
    15.6200/ 4
  • Open / Previous Close
    15.7400 / 15.8900
  • Day Range
    Low 15.5200
    High 16.1500
  • 52 Week Range
    Low 12.9500
    High 25.4700
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 15.89
09:32 ET317815.7
09:34 ET245015.79
09:36 ET130315.794
09:38 ET10015.78
09:39 ET140015.79
09:41 ET10015.8348
09:43 ET54215.85
09:45 ET50015.9
09:48 ET223915.98
09:50 ET44315.97
09:52 ET20016.04
09:54 ET20016.06
09:56 ET20016.15
09:59 ET60016.135
10:01 ET77016.0799
10:03 ET50015.95
10:06 ET50015.9
10:08 ET138315.865
10:10 ET70015.76
10:12 ET72315.75
10:14 ET142815.81
10:15 ET28015.88
10:17 ET168815.87
10:19 ET24415.85
10:21 ET10015.8
10:26 ET18915.815
10:28 ET80015.8292
10:30 ET45515.79
10:32 ET502515.7881
10:33 ET238615.79
10:35 ET10015.775
10:37 ET40015.7
10:39 ET40015.68
10:42 ET20015.65
10:44 ET40015.66
10:46 ET82115.72
10:50 ET70015.7
10:51 ET20015.685
10:55 ET26515.62
10:57 ET20015.62
11:02 ET55015.66
11:04 ET509815.655
11:06 ET51515.69
11:08 ET174615.67
11:09 ET512915.69
11:11 ET73715.65
11:15 ET10015.63
11:20 ET104115.69
11:22 ET20015.69
11:24 ET11115.68
11:26 ET40415.67
11:29 ET71415.64
11:31 ET197215.615
11:33 ET10015.6
11:36 ET283515.6125
11:38 ET82515.59
11:40 ET252415.58
11:42 ET80315.55
11:44 ET30015.55
11:45 ET88915.53
11:47 ET70015.53
11:49 ET51615.55
11:51 ET30115.53
11:56 ET60015.54
11:58 ET80015.59
12:00 ET48815.57
12:02 ET10015.62
12:03 ET72215.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCUS
Arcus Biosciences Inc
United StatesARDX
Ardelyx Inc
United StatesGYRE
Gyre Therapeutics Inc
United StatesVIR
Vir Biotechnology Inc
United StatesNRIX
Nurix Therapeutics Inc
United StatesPRTA
Prothena Corporation PLC
As of 2024-07-17

Company Information

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.

Contact Information

3928 Point Eden WayHAYWARD, CA, United States 94545-3719


Chairman of the Board, Chief Executive Officer, Co-Founder
Terry Rosen
President, Co-Founder
Juan Jaen
Chief Financial Officer
Robert Goeltz
Chief Operating Officer
Jennifer Jarrett
General Counsel
Carolyn Tang

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.